The objective of this Notice of Funding Opportunity (NOFO) is to support the continued development of new and innovative on-demand, event-driven, and long-acting (systemic and non-systemic) multipurpose prevention technologies (MPTs). It supports development of MPTs that prevent HIV infection and pregnancy (hormonal and non-hormonal methods); sexually transmitted infections (STI) and pregnancy; or multiple non-HIV STI or HIV/STI MPTs in cis and trans males and females of all ages. Applications for MPT development may involve pharmacokinetic (PK), pharmacodynamic (PD), safety and, drug-drug interactions (DDI) studies using drug development, and formulation science supported by animal model testing. Also supported are biobehavioral and behavioral/social studies to identify MPT user-desired rheological and biophysical factors (look, feel, effectiveness, safety, and duration of action) and other behavioral/social factors that could promote increased MPT adoption and use.
Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional)
Funding Organization:
The US Department of Health and Human Services National Institutes of Health
Funding Category:
HIV/AIDS
Other Health-Related
STD
Support Types:
Discretionary Grants
Locations:
International
Eligible Organizations:
Fund ID:
PAR-23-180
Application Due Date:
Subjects:
Clinical Research
Data Analysis
HIV
HIV and AIDS Prevention
Medical Treatments and Therapies
Research
STD/STI Prevention
Audiences:
At Risk Persons
Community Based Organizations
Health Professionals
Persons with HIV/AIDS
Persons with STD/STI
Researchers
Last Updated: